Raymond James Reiterates Outperform Rating on Aquestive Therapeutics (AQST)

Go back to Raymond James Reiterates Outperform Rating on Aquestive Therapeutics (AQST)
(NASDAQ: AQST) Delayed: 4.35 +0.12 (2.84%)
Previous Close $4.23    52 Week High
Open $4.25    52 Week Low
Day High $4.39    P/E N/A 
Day Low $4.14    EPS
Volume 1,843,128